Global phase III trial of maintenance phosphatidylcholine as an adjunct to mesalazine for mild to moderate ulcerative colitis.
Phase of Trial: Phase III
Latest Information Update: 11 Apr 2013
At a glance
- Drugs Phosphatidylcholine (Primary) ; Mesalazine
- Indications Ulcerative colitis
- Focus Registrational; Therapeutic Use
- 11 Apr 2013 New trial record